Cargando…
Effectiveness of Palivizumab in High-risk Infants and Children: A Propensity Score Weighted Regression Analysis
BACKGROUND: Infants with premature birth ≤35 weeks gestational age, chronic lung disease of prematurity and congenital heart disease are at an increased risk for lower respiratory tract infections and hospitalization from respiratory syncytial virus (RSV), which has been shown in randomized trials t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516669/ https://www.ncbi.nlm.nih.gov/pubmed/28709160 http://dx.doi.org/10.1097/INF.0000000000001533 |